New Product Launch and Acquisition was the Key Growth Strategy in the In Vitro Toxicology Testing Market between 2013 and 2016

In Vitro Toxicology Testing’s assays including bacterial toxicity assays, enzyme toxicity assays, cell-based ELISA and western blots, receptor binding assays, and tissue culture assays, reagent & labware and services are mainly used for toxicity endpoints & tests including systemic toxicity, dermal toxicity, carcinogenicity, ocular toxicity, skin sensitization & irritation, genotoxicity, neurotoxicity, and organ toxicity.

The global in vitro toxicology testing market was dominated by Agilent Technologies, Inc. (U.S.), and Covance, Inc. (A subsidiary of Laboratory Corporation of American Holdings (LabCorp)) in 2015. With its well established distribution network and broad product portfolio, Agilent Technologies, Inc. held the leadership position in the global in vitro toxicology testing market in 2015. Agilent’s product portfolio includes a vast range of toxicology analysers and application kits, reagents, high performance liquid chromatography (HPLC), and mass spectrometer, etc. Over the past three years, the company adopted the strategy of new product launches and acquisition to maintain its leadership position in the global in vitro toxicology testing market.

Covance, Inc. (A subsidiary of Laboratory Corporation of American Holdings (LabCorp)) (U.S.) held the second position in the in vitro toxicology testing market in 2015. The company has strong geographical presence and robust product portfolio for several endpoints toxicity testing such as systemic toxicity, dermal toxicity, carcinogenicity, ocular toxicity, skin sensitization & irritation, genotoxicity, neurotoxicity, and organ toxicity. The company adopted expansion as its key business strategies to uphold its leading position in the global in vitro toxicology testing market. For instance, in January 2014, Covance, Inc. opened a nutritional chemistry and food safety site in Harrogate, England. This new site helped Covance to enter the food safety and nutritional testing market at a global level.

The major players in this market include Agilent Technologies, Inc. (U.S.), Covance, Inc.  (A subsidiary of LabCorp) (U.S.), Bio-Rad Laboratories, Inc. (U.S.), General Electric Company (U.S.), Eurofins Scientific SE (Luxembourg), BioReliance, Inc. (A subsidiary of Merck & Co, Inc.) (U.S.), Charles River Laboratories International, Inc. (U.S.), Thermo Fisher Scientific, Inc. (U.S.), Catalent (U.S.), and Cyprotex (U.K.).

The global in vitro toxicology testing market is highly evolved, with multiple product segments. An analysis of the market developments between 2013 and 2016 revealed that new product launches and acquisition was the most important growth strategy employed by market leaders in this period. This strategy was adopted by all the players in this market.

The other important growth strategy adopted by players in this market is agreement, collaborations & partnerships and expansion. This strategy was adopted by the players market to enhance their product portfolio. These strategies were adopted by major the players in this market such as Agilent Technologies, Inc. (U.S.), Covance, Inc.  (A subsidiary of LabCorp) (U.S.), Bio-Rad Laboratories, Inc. (U.S.), General Electric Company (U.S.), Eurofins Scientific SE (Luxembourg), Charles River Laboratories International, Inc. (U.S.), Thermo Fisher Scientific, Inc. (U.S.), Catalent (U.S.), and Cyprotex (U.K.). between 2013 and 2015.